Sanofi U.S. Revenue and Competitors

Bridgewater, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sanofi U.S.'s estimated annual revenue is currently $38.5B per year.(i)
  • Sanofi U.S.'s estimated revenue per employee is $371,353
  • Sanofi U.S.'s current valuation is $130.4B. (January 2022)

Employee Data

  • Sanofi U.S. has 103675 Employees.(i)
  • Sanofi U.S. grew their employee count by 2% last year.

Sanofi U.S.'s People

NameTitleEmail/Phone
1
Chief Staff Presidence Global R&DReveal Email/Phone
2
CFO Intercontinental RegionReveal Email/Phone
3
Global Head / VP, Corporate Affairs, General MedicinesReveal Email/Phone
4
CFO Danube RegionReveal Email/Phone
5
Chief Staff - Franchise & Product StrategyReveal Email/Phone
6
Associate VP Medical OperationsReveal Email/Phone
7
CFO Sanofi IsraelReveal Email/Phone
8
Global Procurement Associate VPReveal Email/Phone
9
Associate VP - Head R&D projects (vaccines under development)Reveal Email/Phone
10
CMO partnerships management / CSC operations coordinator at Sanofi Pasteur (Aixial Consultant)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Sanofi U.S.?

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

keywords:N/A

N/A

Total Funding

103675

Number of Employees

$38.5B

Revenue (est)

2%

Employee Growth %

$130.4B

Valuation

N/A

Accelerator

Sanofi U.S. News

2022-04-20 - Stocks To Watch Today: L&T Infotech, Mindtree, Sanofi, Wipro, Ujjivan

U.S. futures gained after stocks ended little changed on Monday. The Singapore-traded SGX Nifty, an early barometer of India's benchmark Nifty 50, rose 0.12% to...

2022-04-19 - Supreme Court wants U.S. to weigh in on Amgen Repatha ...

Amgen sued Sanofi and Regeneron in 2014 after they sought regulatory approval for their rival drug Praluent. The U.S. Food and Drug...

2022-04-19 - Rodolfo Hrosz steps up as new Managing Director of Sanofi India; stock slips ~1%

Before joining Sanofi, he has been associated with top players like Pfizer, LVMH, Heineken, and Procter & Gamble in the USA and Brazil. Sanofi...

2021-11-22 - Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development

November 22, 202112:09 PM UTCLast Updated ago Healthcare & PharmaceuticalsBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development Reuters 2 minute read 1/2 People walk near a Baidu logo at the company headquarters in Beijing, China April 23, 2021. REUTERS/ ...

2021-11-12 - Sanofi announces results of CHMP re-examination of the New Active Substance status for avalglucosidase alfa, a potential new standard of care for the treatment of Pompe disease

Media Update Sanofi announces results of CHMP re-examination of the New Active Substance status for avalglucosidase alfa, a potential new standard of care for the treatment of Pompe disease NOVEMBER 12, 2021 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use ...